Smooth muscle myosin isolated from mammalian vascular tissue or from avian gizzard has a number of unique properties. Addition of approximately stoichiometric amounts of MgATP causes dephosphorylated filaments to depolymerize. The disassembled monomers adopt a conformation in which the 1500 Angstrom long myosin tail is folded into thirds, in contrast to the extended, asymmetric shape characteristic of skeletal myosin. Upon phosphorylation of the regulatory light chain in the myosin head the myosin reassembles into filaments. A major focus of this proposal is to understand the mechanism of these conformational transitions. The role of the light chains and of nucleotide in the folded to extended transition, and the question of whether events originating in the globular head can be directly detected in the rod will be investigated. The myosin conformation in solution will be determined by sedimentation velocity, while electron microscopy of metal-shadowed molecules will be used to resolve structural details. Our observations of rapid subunit exchange between minifilaments will be extended to larger synthetic and native filaments; exchange could be a mechanism by which myosin disassembles from the filament upon MgATP addition. A second major aspect of the proposal is concerned with the enzymatic activity of smooth muscle myosin. Do the two heads of myosin act independently or cooperatively, which kinetic steps are regulated by phosphorylation, and are there any differences between mammalian and avian smooth muscle myosins? The long-term goal of this project is to determine if the folded conformation exists in a smooth muscle cell and, if so, how it affects the function of these cells. Antibodies specific for the folded conformation will be prepared and used as probes to investigate the dynamics of the living muscle cell. It is hoped that through the combined approaches of hydrodynamic analysis, enzymatic activity, electron microscopy and immunology, some insight will be gained about how smooth muscle myosin functions in both normal and diseased vascular tissues.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29HL038113-02
Application #
3470915
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1987-04-01
Project End
1992-03-31
Budget Start
1988-04-01
Budget End
1989-03-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Brandeis University
Department
Type
Organized Research Units
DUNS #
616845814
City
Waltham
State
MA
Country
United States
Zip Code
02454
Taylor, Kenneth A; Feig, Michael; Brooks 3rd, Charles L et al. (2014) Role of the essential light chain in the activation of smooth muscle myosin by regulatory light chain phosphorylation. J Struct Biol 185:375-82
Lowey, Susan; Bretton, Vera; Gulick, James et al. (2013) Transgenic mouse ?- and ?-cardiac myosins containing the R403Q mutation show isoform-dependent transient kinetic differences. J Biol Chem 288:14780-7
Baumann, Bruce A J; Taylor, Dianne W; Huang, Zhong et al. (2012) Phosphorylated smooth muscle heavy meromyosin shows an open conformation linked to activation. J Mol Biol 415:274-87
Ducka, Anna M; Joel, Peteranne; Popowicz, Grzegorz M et al. (2010) Structures of actin-bound Wiskott-Aldrich syndrome protein homology 2 (WH2) domains of Spire and the implication for filament nucleation. Proc Natl Acad Sci U S A 107:11757-62
Lowey, Susan; Trybus, Kathleen M (2010) Common structural motifs for the regulation of divergent class II myosins. J Biol Chem 285:16403-7
Walcott, Sam; Fagnant, Patricia M; Trybus, Kathleen M et al. (2009) Smooth muscle heavy meromyosin phosphorylated on one of its two heads supports force and motion. J Biol Chem 284:18244-51
Trybus, K M; Lowey, S (1987) Assembly of smooth muscle myosin minifilaments: effects of phosphorylation and nucleotide binding. J Cell Biol 105:3007-19